Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma-Reference-Cited by-同舟云学术

Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma

Published:2017-05-15 Issue:5 Volume:12 Page:e0177486
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boyé Pierre^ORCID,Serres François,Marescaux Laurent,Hordeaux Juliette,Bouchaert Emmanuel,Gomes Bruno,Tierny Dominique

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Cancer statistics, 2013;R Siegel,2013

2. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study;A Younes,2014

3. Etoposide: four decades of development of a topoisomerase II inhibitor;KR Hande,1998

4. Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin’s lymphoma;JK Doorduijn,2000

5. Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin’s lymphoma;L-J Bo,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study of chemotherapy protocols for lymphoma in dogs;International Journal of Veterinary Medicine;2024-04-02

2. Topoisomerase IIα immunoexpression in feline mammary carcinomas: A correlation with Ki67 immunoexpression and the mitotic count;Research in Veterinary Science;2023-11

3. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

4. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

5. Toxicity of Etopozid in the treatment of cats with lymphoma;Legal regulation in veterinary medicine;2023-07-21